SlideShare a Scribd company logo
Dental prototype modelling tool
guidance presentation
You do not need to press any keys but if you do
the slide will advance, disabling the animation
features on that slide. It will then continue
automatically from the next slide
This is an animated presentation
The modelling tool can be used for:
• Understanding the practice forecast year-end
position based on current delivery positions
• Allowing practices to estimate the numbers of
patients/activity needed to meet contract
requirements at year-end
Using the modelling tool:
• Where cells are green, practices need to input
figures
• Where cells are white calculations are done
automatically for you
What you will require
1) Capitation remuneration report 2) Modelling tool
Prototype practice year-end calculation modelling tool
Cells requiring manual input
Practice name
Practice information (from capitation remuneration report)
Actual Annual Prototype Value (AAPV)
Capitation element (AAPV-C)
Activity element (AAPV-A)
Expected patient list (CECP)
Transitional allowance
Expected Capitated Population 0 less transitional allow ance
Expected Minimum Activity (EMA)
Contract value c/fwd - previous year (£)
Estimated year-end delivery percentage (practice's own figures)
Prototype UDAs (number); or
Prototype UDAs (percentage)
Estimated patient numbers
Estimated UDAs 0
Step 1 - Year end delivery percentage for capitation and activity
Capitation #DIV/0!
Activity #DIV/0!
Step 2 - Apply rules for adjustments for activity and capitation delivery (exchange mechanism)
Capitation #DIV/0!
Activity #DIV/0!
Step 3 - Combine the year end achievement for capitation and activty
Capitation #DIV/0!
Activity #DIV/0!
Total #DIV/0!
% total #DIV/0!
Step 4 - Apply carry forward from previous year
Carry forward from previous year £0.00
#DIV/0!
% total #DIV/0!
Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML)
Total #DIV/0!
% total #DIV/0! #DIV/0!
Step 5 - Calculate the final position and carry forward (if applicable) for next year
Initial year-end value #DIV/0!
Initial year-end percentage #DIV/0!
Step 5a - Apply tolerances to carry forward figures
Final year-end value #DIV/0! #DIV/0!
Final year-end percentage #DIV/0!
For every 100 UDAs below your expected
minimum activity level (EMA)
#DIV/0! extra patients are required to
achieve the same financial value
Required patients at March 2018 (minus transitional allowance)
Actual Annual Prototype Value - Capitation Element (AAPV-C)
Actual Annual Prototype Value - Activity Element (AAPV-A)
Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A)
Month
36 - month actual
capitated patient
numbers (new
rules)
New joiners
needed per
remaining month
(new rules)
New joiners
needed plus
imminent lapsers
% of expected
patient numbers
currently delivering
(new rules)
% of expected
patient numbers
currently
delivering
including
transitional
allowance
Apr-17 14500 42 97% 98% 12
May-17 14600 36 97% 99% 11
Jun-17 14650 35 98% 99% 10
Jul-17 14700 33 98% 99% 9
Aug-17 14750 31 98% 100% 8
Sep-17 14850 21 99% 100% 7
Oct-17 14900 17 99% 101% 6
Nov-17 14925 15 138 100% 101% 5
Dec-17
Jan-18
Feb-18
Mar-18
Month
Prototype UDAs
carried out in
month
Prototype UDAs
cumulative total
Expected
prototype UDAs
% of expected
Prototype UDAs
achieved
RAG Green100%
or
Apr-17 1300 1300 1542 84% 1
May-17 1500 2800 3083 91% 2
Jun-17 1600 4400 4625 95% 3
Jul-17 1300 5700 6167 92% 4
Aug-17 1400 7100 7708 92% 5
Sep-17 1400 8500 9250 92% 6
Oct-17 1500 10000 10792 93% 7
Nov-17 1300 11300 12333 92% 8
Dec-17 11300 13875 9
Jan-18 11300 15417 10
Feb-18 11300 16958 11
Mar-18 11300 18500 12
Month
Total Scheduled
UDAs
Total UDAs
completed in
month
Apr-17 4000 5000
May-17 3500 4000
Jun-17 5000 6000
Jul-17 4700 5000
Aug-17 5000 6000
Sep-17 4800 5000
Oct-17 5200 4000
Nov-17 3800 1000
Dec-17
Jan-18
Feb-18
Mar-18
£1,255,000.00
Start date for prototype 01/04/2016
2017-18delivery requirements
Contract Value Carried Forward - Previous Year £5,000.00
XXXXX Dental
Prototype blend A
£725,000.00
£530,000.00
Total UDAs delivered - Scheduled activity vs. activity completed in month
2016017Capitation remuneration report - Prototype XXXXXXXX- November 2017
14,800
Expected Minimum Activity 18,500
Activity and Capitation Performance Tolerance
Contractor's Expected Capitated Population 15,000
2016-17 transitional allowance (provisional) 200
Capitated patient list - patients seen in 36months
Activity - Prototype UDAs delivered
Provider name or company name
Prototype reference number
95%
96%
96%
97%
97%
98%
98%
99%
99%
100%
100%
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
Series2
0
1000
2000
3000
4000
5000
6000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
The capitation remuneration
report can be found on
Compass
The modelling tool can be
downloaded from www.pcc-
cic.org.uk/article/making-it-work-
practice
Required patients at March 2018 (minus transitional allowance)
Actual Annual Prototype Value - Capitation Element (AAPV-C)
Actual Annual Prototype Value - Activity Element (AAPV-A)
Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A)
Month
36 - month actual
capitated patient
numbers (new
rules)
New joiners
needed per
remaining month
(new rules)
New joiners
needed plus
imminent lapsers
% of expected
patient numbers
currently delivering
(new rules)
% of expected
patient numbers
currently
delivering
including
transitional
allowance
Apr-17 14500 42 97% 98% 12
May-17 14600 36 97% 99% 11
Jun-17 14650 35 98% 99% 10
Jul-17 14700 33 98% 99% 9
Aug-17 14750 31 98% 100% 8
Sep-17 14850 21 99% 100% 7
Oct-17 14900 17 99% 101% 6
Nov-17 14925 15 138 100% 101% 5
Dec-17
Jan-18
Feb-18
Mar-18
Month
Prototype UDAs
carried out in
month
Prototype UDAs
cumulative total
Expected
prototype UDAs
% of expected
Prototype UDAs
achieved
RAG Green100%
or
Apr-17 1300 1300 1542 84% 1
May-17 1500 2800 3083 91% 2
Jun-17 1600 4400 4625 95% 3
Jul-17 1300 5700 6167 92% 4
Aug-17 1400 7100 7708 92% 5
Sep-17 1400 8500 9250 92% 6
Oct-17 1500 10000 10792 93% 7
Nov-17 1300 11300 12333 92% 8
Dec-17 11300 13875 9
Jan-18 11300 15417 10
Feb-18 11300 16958 11
Mar-18 11300 18500 12
Month
Total Scheduled
UDAs
Total UDAs
completed in
month
Apr-17 4000 5000
May-17 3500 4000
Jun-17 5000 6000
Jul-17 4700 5000
Aug-17 5000 6000
Sep-17 4800 5000
Oct-17 5200 4000
Nov-17 3800 1000
Dec-17
Jan-18
Feb-18
Mar-18
£1,255,000.00
Start date for prototype 01/04/2016
2017-18delivery requirements
Contract Value Carried Forward - Previous Year £5,000.00
XXXXX Dental
Prototype blend A
£725,000.00
£530,000.00
Total UDAs delivered - Scheduled activity vs. activity completed in month
2016017Capitation remuneration report - Prototype XXXXXXXX- November 2017
14,800
Expected Minimum Activity 18,500
Activity and Capitation Performance Tolerance
Contractor's Expected Capitated Population 15,000
2016-17 transitional allowance (provisional) 200
Capitated patient list - patients seen in 36months
Activity - Prototype UDAs delivered
Provider name or company name
Prototype reference number
95%
96%
96%
97%
97%
98%
98%
99%
99%
100%
100%
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
Series2
0
1000
2000
3000
4000
5000
6000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
Capitation remuneration report
These figures need to be
entered into the “Practice
information” section of
the modelling tool
Capitation
section
Activity
section These figures can either be used
directly, or can be used to
calculate estimated figures for
input into the “Estimated year-
end delivery percentage”
section of the modelling tool
Prototype practice year-end calculation modelling tool
Cells requiring manual input
Practice name
Practice information (from capitation remuneration report)
Actual Annual Prototype Value (AAPV)
Capitation element (AAPV-C)
Activity element (AAPV-A)
Expected patient list (CECP)
Transitional allowance
Expected Capitated Population 0 less transitional allow ance
Expected Minimum Activity (EMA)
Contract value c/fwd - previous year (£)
Estimated year-end delivery percentage (practice's own figures)
Prototype UDAs (number); or
Prototype UDAs (percentage)
Estimated patient numbers
Estimated UDAs 0
Step 1 - Year end delivery percentage for capitation and activity
Capitation #DIV/0!
Activity #DIV/0!
Step 2 - Apply rules for adjustments for activity and capitation delivery (exchange mechanism)
Capitation #DIV/0!
Activity #DIV/0!
Step 3 - Combine the year end achievement for capitation and activty
Capitation #DIV/0!
Activity #DIV/0!
Total #DIV/0!
% total #DIV/0!
Step 4 - Apply carry forward from previous year
Carry forward from previous year £0.00
#DIV/0!
% total #DIV/0!
Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML)
Total #DIV/0!
% total #DIV/0! #DIV/0!
Step 5 - Calculate the final position and carry forward (if applicable) for next year
Initial year-end value #DIV/0!
Initial year-end percentage #DIV/0!
Step 5a - Apply tolerances to carry forward figures
Final year-end value #DIV/0! #DIV/0!
Final year-end percentage #DIV/0!
For every 100 UDAs below your expected
minimum activity level (EMA)
#DIV/0! extra patients are required to
achieve the same financial value
The figures from the top
section of the capitation
remuneration report are
entered here
The actual, or estimated
figures, based on the
capitation and activity
sections of the
capitation remuneration
report are entered here
Prior year under-performance
Required patients at March 2018 (minus transitional allowance)
Actual Annual Prototype Value - Capitation Element (AAPV-C)
Actual Annual Prototype Value - Activity Element (AAPV-A)
Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A)
Start date for prototype 01/04/2016
2017-18delivery requirements
Contract Value Carried Forward - Previous Year
Prototype blend A
2016017Capitation remuneration report - Prototype XXXXXXXX- November2017
Expected Minimum Activity
Activity and Capitation Performance Tolerance
Contractor's Expected Capitated Population
2016-17 transitional allowance (provisional)
Provider name or company name
Prototype reference number
Prototype practice year-end calculation modelling tool
Cells requiring manual input
Practice name
Practice information (from capitation remuneration report)
Actual Annual Prototype Value (AAPV)
Capitation element (AAPV-C)
Activity element (AAPV-A)
Expected patient list (CECP)
Transitional allowance
Expected Capitated Population 0
Expected Minimum Activity (EMA)
Contract value c/fwd - previous year (£)
Estimated year-end delivery percentage (practice's own figures)
Prototype UDAs (number); or
Prototype UDAs (percentage)
Estimated patient numbers
Estimated UDAs 0
£725,000
£530,000
15,000
200
14,800
18,500
XXXXX Dental
(2) The modelling tool will identify
whether this represents prior year
under or over-performance
(1) Please ensure that you populate the
modelling tool with the appropriate
figures from the top section of the
capitation remuneration report Iike this
XXXXX Dental
£1,255,000
£725,000
£530,000
15,000
£1,255,000
200
18,500
£5,000£5,000
(3) Input one figure in respect of
estimated UDAs, either a percentage
estimate or an actual number in the
appropriate cell
(4) Input the capitation figure from the
latest capitation remuneration report , or your
own forecast figure
This is a sub-total
Top section of the capitation remuneration report
1
2
4
5
3
2
3
1
4
6
5
6
7
8
7
8
Required patients at March 2018 (minus transitional allowance)
Actual Annual Prototype Value - Capitation Element (AAPV-C)
Actual Annual Prototype Value - Activity Element (AAPV-A)
Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A)
Month
36 - month actual
capitated patient
numbers (new
rules)
New joiners
needed per
remaining month
(new rules)
New joiners
needed plus
imminent lapsers
% of expected
patient numbers
currently delivering
(new rules)
% of expected
patient numbers
currently
delivering
including
transitional
allowance
Apr-17 14500 42 97% 98% 12
May-17 14600 36 97% 99% 11
Jun-17 14650 35 98% 99% 10
Jul-17 14700 33 98% 99% 9
Aug-17 14750 31 98% 100% 8
Sep-17 14850 21 99% 100% 7
Oct-17 14900 17 99% 101% 6
Nov-17 14925 15 138 100% 101% 5
Dec-17
Jan-18
Feb-18
Mar-18
£1,255,000.00
Start date for prototype 01/04/2016
2017-18 delivery requirements
Contract Value Carried Forward - Previous Year £5,000.00
XXXXX Dental
Prototype blend A
£725,000.00
£530,000.00
2016017 Capitation remuneration report - Prototype XXXXXXXX- November 2017
14,800
Expected Minimum Activity 18,500
Activity and Capitation Performance Tolerance
Contractor's Expected Capitated Population 15,000
2016-17 transitional allowance (provisional) 200
Capitated patient list - patients seen in 36 months
Provider name or company name
Prototype reference number
95%
96%
96%
97%
97%
98%
98%
99%
99%
100%
100%
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
Capitation figures – Where do I get them from?
Top half of the November 2017 capitation remuneration report
(1) Identify the month that the
report relates to
(2) Identify the capitation figure
for that month for the modelling
tool, or use your own estimate
Activity figures – Where do I get them from?
Month
Prototype UDAs
carried out in
month
Prototype UDAs
cumulative total
Expected
prototype UDAs
% of expected
Prototype UDAs
achieved
RAG Green100%
or
Apr-17 350 350 583 60%
May-17 320 670 1167 57%
Jun-17 300 970 1750 55%
Jul-17 270 1240 2333 53%
Aug-17 370 1610 2917 55%
Sep-17 380 1990 3500 57%
Oct-17 230 2220 4083 54%
Nov-17 400 2620 4667 56%
Dec-17 2620 5250
Jan-18 2620 5833
Feb-18 2620 6417
Mar-18 2620 7000
Month
Total Scheduled
UDAs
Total UDAs
completed in
month
Apr-17 300 600
May-17 530 560
Jun-17 430 530
Jul-17 650 540
Aug-17 587 480
Sep-17 483 600
Oct-17 670 670
Nov-17 730 400
Dec-17
Jan-18
Feb-18
Mar-18
Total UDAs delivered - Scheduled activity vs. activity completed in month
Activity - Prototype UDAs delivered
0
1000
2000
3000
4000
5000
6000
7000
8000
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Series1
Series2
0
100
200
300
400
500
600
700
800
0
100
200
300
400
500
600
700
800
Bottom half of the November 2017 capitation remuneration report
(1) From the top half of the
report, identify the month that
the report relates to. This is the
November 2017 report
(2) Identify the month that is
two months earlier than the
reporting month. This is because
practices have two months to
submit claims
(3) Select the percentage
achievement from the month two
months earlier than the reporting
month to enter into the modelling
tool, or use your own estimate
What do the modelling tool figures mean?
Prototype practice year-end calculation modelling tool
Cells requiring manual input
Practice name XXXXX Dental
Practice information (from capitation remuneration report)
Actual Annual Prototype Value (AAPV) £1,255,000.00
Capitation element (AAPV-C) £725,000.00
Activity element (AAPV-A) £530,000.00
Expected patient list (CECP) 15,000
Transitional allowance 200
Expected Capitated Population 14,800 less transitional allow ance
Expected Minimum Activity (EMA) 18,500
Contract value c/fwd - previous year (£) £5,000.00 Prior year under-performance
Estimated year-end delivery percentage (practice's own figures)
Prototype UDAs (number); or
Prototype UDAs (percentage) 92.00%
Estimated patient numbers 14,925
Estimated UDAs 17,020
Modelling tool – top half
(1) You will have input these
figures into the modelling tool as
explained in slide 6 earlier in the
presentation
(2) Now input your estimated
capitation and activity figures,
either based on the capitation
remuneration report or you
own calculations
Step 1 - Year end deliverypercentage for capitation and activity
Capitation 100.83%
Activity 92.00%
Step 2 - Applyrules for adjustments for activityand capitation delivery(exchange mechanism)
Capitation 100.83%
Activity 92.00%
Step 3 - Combine the year end achievement for capitation and activty
Capitation £731,041.67
Activity £487,600.00
Total £1,218,641.67
% total 97.10%
Step 4 - Applycarryforward fromprevious year
Carry forward from previous year Prior year under-performance £5,000.00
£1,213,641.67
% total 96.70%
Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML)
Total £1,213,641.67
% total 96.70%
Step 5 - Calculate the final position and carryforward (if applicable) for next year
Initial year-end value £41,358.33
Initial year-end percentage 3.30%
Step 5a - Applytolerances to carryforward figures
Final year-end value Under-performance £41,358.33
Final year-end percentage 3.30%
For every 100 UDAs below your expected
minimum activity level (EMA)
59.27 extra patients are required to
achieve the same financial value
Modelling tool – bottom half
Step 1 – Raw capitation and
activity performance
Step 2 – Exchange mechanism
rules are applied to raw capitation and
activity performance, if criteria are
met
Step 3 – The step 2 percentages
are then applied separately to the
capitation and activity contract
values and added together to give
an overall total
Step 4 – The step 3 total value
is then adjusted to take into
account any carry forward from the
previous year. A revised
percentage is calculated
Step 4a – Only applies to cases
where the step 4 overall percentage
is less than 90%. This step limits the
under- performance to 90%,
otherwise the step 4 total appliesStep 5 – This calculates the final
year-end carry forward figure where
appropriate, or identifies the amount
to be paid back where performance is
less than 96%
Step 5a – only applies where
the practice over-performs by more
than 2%. This step limits any over-
performance to 2%, otherwise the
step 5 total applies
Exchange mechanism
The exchange mechanism enables practices to offset under-
performance on activity by over-performance on capitation, NOT
vice-versa.
Where practices utilise the exchange
mechanism, the bottom of the modelling
tool states how many additional patients you
need to see for every 100 UDAs you are
below your expected minimum activity
For every 100 UDAs below your expected
minimum activity level (EMA)
59.27 extra patients are required to
achieve the same financial value
A separate exchange mechanism briefing will be published separately
Further support
If you still require further assistance please
contact
dentalcontractreform@pcc.nhs.uk
The modelling tool can be downloaded from
www.pcc-cic.org.uk/article/making-it-work-practice

More Related Content

Similar to Modelling tool guidance presentation animated version 3 unlocked

SIMA Strategy Final
SIMA Strategy FinalSIMA Strategy Final
SIMA Strategy Final
Hamdy Alshazly
 
TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017
Share Rora
 
Catalyst 2016: EnergyCAP Health Checkup
Catalyst 2016: EnergyCAP Health CheckupCatalyst 2016: EnergyCAP Health Checkup
Catalyst 2016: EnergyCAP Health Checkup
EnergyCAP, Inc.
 
6.2 building a financial model.pptx
6.2 building a financial model.pptx6.2 building a financial model.pptx
6.2 building a financial model.pptx
Rick Rasmussen
 
Financial_accounting_samsung_singapore_air_line.pptx
Financial_accounting_samsung_singapore_air_line.pptxFinancial_accounting_samsung_singapore_air_line.pptx
Financial_accounting_samsung_singapore_air_line.pptx
blueskygreenfield6
 
GMF 2016 Interim Results
GMF 2016 Interim ResultsGMF 2016 Interim Results
GMF 2016 Interim Results
Nick Ross
 
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
Future Managers
 
[2017] Penn-Case-Book-with-Practice-Cases.pdf
[2017] Penn-Case-Book-with-Practice-Cases.pdf[2017] Penn-Case-Book-with-Practice-Cases.pdf
[2017] Penn-Case-Book-with-Practice-Cases.pdf
zidanhusain
 
Ch14 aggt.sales+&+op.planning
Ch14 aggt.sales+&+op.planningCh14 aggt.sales+&+op.planning
Ch14 aggt.sales+&+op.planning
videoaakash15
 
Ch14 aggt.sales & op.planning
Ch14 aggt.sales & op.planningCh14 aggt.sales & op.planning
Ch14 aggt.sales & op.planning
videoaakash15
 
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docxExtra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
nealwaters20034
 
ROI of Machine Learning In IoT
ROI of Machine Learning In IoTROI of Machine Learning In IoT
ROI of Machine Learning In IoT
Value Amplify Consulting
 
UTSFinmagecapitalbugproject
UTSFinmagecapitalbugprojectUTSFinmagecapitalbugproject
UTSFinmagecapitalbugproject
Joshua C
 
Variance Analysis.pptx
 Variance Analysis.pptx Variance Analysis.pptx
Variance Analysis.pptx
VrutikJentibhaiSangh
 
Chapter 06
Chapter 06Chapter 06
1 Huffman Trucking Memo To All Senior Staff F.docx
1 Huffman Trucking Memo To All Senior Staff F.docx1 Huffman Trucking Memo To All Senior Staff F.docx
1 Huffman Trucking Memo To All Senior Staff F.docx
mercysuttle
 
Cw 3 q'16 earnings presentation final
Cw 3 q'16 earnings presentation finalCw 3 q'16 earnings presentation final
Cw 3 q'16 earnings presentation final
q4curtisswright
 
OpenText Live: Modeling your business processes to new ways of working
OpenText Live: Modeling your business processes to new ways of workingOpenText Live: Modeling your business processes to new ways of working
OpenText Live: Modeling your business processes to new ways of working
OpenText Portfolio
 
Ch5 pw analysis_part1_rev4
Ch5 pw analysis_part1_rev4Ch5 pw analysis_part1_rev4
Ch5 pw analysis_part1_rev4
Nour Dagher
 
Bud Geting
Bud GetingBud Geting

Similar to Modelling tool guidance presentation animated version 3 unlocked (20)

SIMA Strategy Final
SIMA Strategy FinalSIMA Strategy Final
SIMA Strategy Final
 
TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017
 
Catalyst 2016: EnergyCAP Health Checkup
Catalyst 2016: EnergyCAP Health CheckupCatalyst 2016: EnergyCAP Health Checkup
Catalyst 2016: EnergyCAP Health Checkup
 
6.2 building a financial model.pptx
6.2 building a financial model.pptx6.2 building a financial model.pptx
6.2 building a financial model.pptx
 
Financial_accounting_samsung_singapore_air_line.pptx
Financial_accounting_samsung_singapore_air_line.pptxFinancial_accounting_samsung_singapore_air_line.pptx
Financial_accounting_samsung_singapore_air_line.pptx
 
GMF 2016 Interim Results
GMF 2016 Interim ResultsGMF 2016 Interim Results
GMF 2016 Interim Results
 
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
NCV 4 New Venture Creation Hands-On Support Slide Show - Module 5
 
[2017] Penn-Case-Book-with-Practice-Cases.pdf
[2017] Penn-Case-Book-with-Practice-Cases.pdf[2017] Penn-Case-Book-with-Practice-Cases.pdf
[2017] Penn-Case-Book-with-Practice-Cases.pdf
 
Ch14 aggt.sales+&+op.planning
Ch14 aggt.sales+&+op.planningCh14 aggt.sales+&+op.planning
Ch14 aggt.sales+&+op.planning
 
Ch14 aggt.sales & op.planning
Ch14 aggt.sales & op.planningCh14 aggt.sales & op.planning
Ch14 aggt.sales & op.planning
 
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docxExtra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
Extra Credit Assignment, Econ 140 (3)Choose any topic discussed.docx
 
ROI of Machine Learning In IoT
ROI of Machine Learning In IoTROI of Machine Learning In IoT
ROI of Machine Learning In IoT
 
UTSFinmagecapitalbugproject
UTSFinmagecapitalbugprojectUTSFinmagecapitalbugproject
UTSFinmagecapitalbugproject
 
Variance Analysis.pptx
 Variance Analysis.pptx Variance Analysis.pptx
Variance Analysis.pptx
 
Chapter 06
Chapter 06Chapter 06
Chapter 06
 
1 Huffman Trucking Memo To All Senior Staff F.docx
1 Huffman Trucking Memo To All Senior Staff F.docx1 Huffman Trucking Memo To All Senior Staff F.docx
1 Huffman Trucking Memo To All Senior Staff F.docx
 
Cw 3 q'16 earnings presentation final
Cw 3 q'16 earnings presentation finalCw 3 q'16 earnings presentation final
Cw 3 q'16 earnings presentation final
 
OpenText Live: Modeling your business processes to new ways of working
OpenText Live: Modeling your business processes to new ways of workingOpenText Live: Modeling your business processes to new ways of working
OpenText Live: Modeling your business processes to new ways of working
 
Ch5 pw analysis_part1_rev4
Ch5 pw analysis_part1_rev4Ch5 pw analysis_part1_rev4
Ch5 pw analysis_part1_rev4
 
Bud Geting
Bud GetingBud Geting
Bud Geting
 

More from maxford1979

Edit delete-replacev3
Edit delete-replacev3Edit delete-replacev3
Edit delete-replacev3
maxford1979
 
Discussion forumsv3
Discussion forumsv3Discussion forumsv3
Discussion forumsv3
maxford1979
 
Hide show this networkv2
Hide show this networkv2Hide show this networkv2
Hide show this networkv2
maxford1979
 
Items shown on network feedv2
Items shown on network feedv2Items shown on network feedv2
Items shown on network feedv2
maxford1979
 
Information and membership policyv2
Information and membership policyv2Information and membership policyv2
Information and membership policyv2
maxford1979
 
Change and delete imagev2
Change and delete imagev2Change and delete imagev2
Change and delete imagev2
maxford1979
 
Find affiliatesv2
Find affiliatesv2Find affiliatesv2
Find affiliatesv2
maxford1979
 
Email network membersv2
Email network membersv2Email network membersv2
Email network membersv2
maxford1979
 
View modify network membersv2
View modify network membersv2View modify network membersv2
View modify network membersv2
maxford1979
 
Import membersv2
Import membersv2Import membersv2
Import membersv2
maxford1979
 
Invite someone to join this networkv2
Invite someone to join this networkv2Invite someone to join this networkv2
Invite someone to join this networkv2
maxford1979
 
Page
PagePage
Add a documentv3
Add a documentv3Add a documentv3
Add a documentv3
maxford1979
 
Blogv2
Blogv2Blogv2
Blogv2
maxford1979
 
Audio video slideshow updated july2016v2
Audio video slideshow updated july2016v2Audio video slideshow updated july2016v2
Audio video slideshow updated july2016v2
maxford1979
 
Eventsv2
Eventsv2Eventsv2
Eventsv2
maxford1979
 
Add a news storyv2
Add a news storyv2Add a news storyv2
Add a news storyv2
maxford1979
 
Polls
PollsPolls
Add a new folderv3
Add a new folderv3Add a new folderv3
Add a new folderv3
maxford1979
 
Add a press clippingv3
Add a press clippingv3Add a press clippingv3
Add a press clippingv3
maxford1979
 

More from maxford1979 (20)

Edit delete-replacev3
Edit delete-replacev3Edit delete-replacev3
Edit delete-replacev3
 
Discussion forumsv3
Discussion forumsv3Discussion forumsv3
Discussion forumsv3
 
Hide show this networkv2
Hide show this networkv2Hide show this networkv2
Hide show this networkv2
 
Items shown on network feedv2
Items shown on network feedv2Items shown on network feedv2
Items shown on network feedv2
 
Information and membership policyv2
Information and membership policyv2Information and membership policyv2
Information and membership policyv2
 
Change and delete imagev2
Change and delete imagev2Change and delete imagev2
Change and delete imagev2
 
Find affiliatesv2
Find affiliatesv2Find affiliatesv2
Find affiliatesv2
 
Email network membersv2
Email network membersv2Email network membersv2
Email network membersv2
 
View modify network membersv2
View modify network membersv2View modify network membersv2
View modify network membersv2
 
Import membersv2
Import membersv2Import membersv2
Import membersv2
 
Invite someone to join this networkv2
Invite someone to join this networkv2Invite someone to join this networkv2
Invite someone to join this networkv2
 
Page
PagePage
Page
 
Add a documentv3
Add a documentv3Add a documentv3
Add a documentv3
 
Blogv2
Blogv2Blogv2
Blogv2
 
Audio video slideshow updated july2016v2
Audio video slideshow updated july2016v2Audio video slideshow updated july2016v2
Audio video slideshow updated july2016v2
 
Eventsv2
Eventsv2Eventsv2
Eventsv2
 
Add a news storyv2
Add a news storyv2Add a news storyv2
Add a news storyv2
 
Polls
PollsPolls
Polls
 
Add a new folderv3
Add a new folderv3Add a new folderv3
Add a new folderv3
 
Add a press clippingv3
Add a press clippingv3Add a press clippingv3
Add a press clippingv3
 

Recently uploaded

Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
Apollo 24/7 Adult & Paediatric Emergency Services
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
SatvikaPrasad
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Anxiety, Trauma and Stressor Related Disorder.pptx
Anxiety, Trauma and Stressor Related Disorder.pptxAnxiety, Trauma and Stressor Related Disorder.pptx
Anxiety, Trauma and Stressor Related Disorder.pptx
Sagunlohala1
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
R3 Stem Cell
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 

Recently uploaded (20)

Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
 
Feeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptxFeeding plate for a newborn with Cleft Palate.pptx
Feeding plate for a newborn with Cleft Palate.pptx
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Anxiety, Trauma and Stressor Related Disorder.pptx
Anxiety, Trauma and Stressor Related Disorder.pptxAnxiety, Trauma and Stressor Related Disorder.pptx
Anxiety, Trauma and Stressor Related Disorder.pptx
 
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyDr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in Cardiology
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 

Modelling tool guidance presentation animated version 3 unlocked

  • 1. Dental prototype modelling tool guidance presentation You do not need to press any keys but if you do the slide will advance, disabling the animation features on that slide. It will then continue automatically from the next slide This is an animated presentation
  • 2. The modelling tool can be used for: • Understanding the practice forecast year-end position based on current delivery positions • Allowing practices to estimate the numbers of patients/activity needed to meet contract requirements at year-end Using the modelling tool: • Where cells are green, practices need to input figures • Where cells are white calculations are done automatically for you
  • 3. What you will require 1) Capitation remuneration report 2) Modelling tool Prototype practice year-end calculation modelling tool Cells requiring manual input Practice name Practice information (from capitation remuneration report) Actual Annual Prototype Value (AAPV) Capitation element (AAPV-C) Activity element (AAPV-A) Expected patient list (CECP) Transitional allowance Expected Capitated Population 0 less transitional allow ance Expected Minimum Activity (EMA) Contract value c/fwd - previous year (£) Estimated year-end delivery percentage (practice's own figures) Prototype UDAs (number); or Prototype UDAs (percentage) Estimated patient numbers Estimated UDAs 0 Step 1 - Year end delivery percentage for capitation and activity Capitation #DIV/0! Activity #DIV/0! Step 2 - Apply rules for adjustments for activity and capitation delivery (exchange mechanism) Capitation #DIV/0! Activity #DIV/0! Step 3 - Combine the year end achievement for capitation and activty Capitation #DIV/0! Activity #DIV/0! Total #DIV/0! % total #DIV/0! Step 4 - Apply carry forward from previous year Carry forward from previous year £0.00 #DIV/0! % total #DIV/0! Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML) Total #DIV/0! % total #DIV/0! #DIV/0! Step 5 - Calculate the final position and carry forward (if applicable) for next year Initial year-end value #DIV/0! Initial year-end percentage #DIV/0! Step 5a - Apply tolerances to carry forward figures Final year-end value #DIV/0! #DIV/0! Final year-end percentage #DIV/0! For every 100 UDAs below your expected minimum activity level (EMA) #DIV/0! extra patients are required to achieve the same financial value Required patients at March 2018 (minus transitional allowance) Actual Annual Prototype Value - Capitation Element (AAPV-C) Actual Annual Prototype Value - Activity Element (AAPV-A) Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A) Month 36 - month actual capitated patient numbers (new rules) New joiners needed per remaining month (new rules) New joiners needed plus imminent lapsers % of expected patient numbers currently delivering (new rules) % of expected patient numbers currently delivering including transitional allowance Apr-17 14500 42 97% 98% 12 May-17 14600 36 97% 99% 11 Jun-17 14650 35 98% 99% 10 Jul-17 14700 33 98% 99% 9 Aug-17 14750 31 98% 100% 8 Sep-17 14850 21 99% 100% 7 Oct-17 14900 17 99% 101% 6 Nov-17 14925 15 138 100% 101% 5 Dec-17 Jan-18 Feb-18 Mar-18 Month Prototype UDAs carried out in month Prototype UDAs cumulative total Expected prototype UDAs % of expected Prototype UDAs achieved RAG Green100% or Apr-17 1300 1300 1542 84% 1 May-17 1500 2800 3083 91% 2 Jun-17 1600 4400 4625 95% 3 Jul-17 1300 5700 6167 92% 4 Aug-17 1400 7100 7708 92% 5 Sep-17 1400 8500 9250 92% 6 Oct-17 1500 10000 10792 93% 7 Nov-17 1300 11300 12333 92% 8 Dec-17 11300 13875 9 Jan-18 11300 15417 10 Feb-18 11300 16958 11 Mar-18 11300 18500 12 Month Total Scheduled UDAs Total UDAs completed in month Apr-17 4000 5000 May-17 3500 4000 Jun-17 5000 6000 Jul-17 4700 5000 Aug-17 5000 6000 Sep-17 4800 5000 Oct-17 5200 4000 Nov-17 3800 1000 Dec-17 Jan-18 Feb-18 Mar-18 £1,255,000.00 Start date for prototype 01/04/2016 2017-18delivery requirements Contract Value Carried Forward - Previous Year £5,000.00 XXXXX Dental Prototype blend A £725,000.00 £530,000.00 Total UDAs delivered - Scheduled activity vs. activity completed in month 2016017Capitation remuneration report - Prototype XXXXXXXX- November 2017 14,800 Expected Minimum Activity 18,500 Activity and Capitation Performance Tolerance Contractor's Expected Capitated Population 15,000 2016-17 transitional allowance (provisional) 200 Capitated patient list - patients seen in 36months Activity - Prototype UDAs delivered Provider name or company name Prototype reference number 95% 96% 96% 97% 97% 98% 98% 99% 99% 100% 100% Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 Series2 0 1000 2000 3000 4000 5000 6000 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 The capitation remuneration report can be found on Compass The modelling tool can be downloaded from www.pcc- cic.org.uk/article/making-it-work- practice
  • 4. Required patients at March 2018 (minus transitional allowance) Actual Annual Prototype Value - Capitation Element (AAPV-C) Actual Annual Prototype Value - Activity Element (AAPV-A) Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A) Month 36 - month actual capitated patient numbers (new rules) New joiners needed per remaining month (new rules) New joiners needed plus imminent lapsers % of expected patient numbers currently delivering (new rules) % of expected patient numbers currently delivering including transitional allowance Apr-17 14500 42 97% 98% 12 May-17 14600 36 97% 99% 11 Jun-17 14650 35 98% 99% 10 Jul-17 14700 33 98% 99% 9 Aug-17 14750 31 98% 100% 8 Sep-17 14850 21 99% 100% 7 Oct-17 14900 17 99% 101% 6 Nov-17 14925 15 138 100% 101% 5 Dec-17 Jan-18 Feb-18 Mar-18 Month Prototype UDAs carried out in month Prototype UDAs cumulative total Expected prototype UDAs % of expected Prototype UDAs achieved RAG Green100% or Apr-17 1300 1300 1542 84% 1 May-17 1500 2800 3083 91% 2 Jun-17 1600 4400 4625 95% 3 Jul-17 1300 5700 6167 92% 4 Aug-17 1400 7100 7708 92% 5 Sep-17 1400 8500 9250 92% 6 Oct-17 1500 10000 10792 93% 7 Nov-17 1300 11300 12333 92% 8 Dec-17 11300 13875 9 Jan-18 11300 15417 10 Feb-18 11300 16958 11 Mar-18 11300 18500 12 Month Total Scheduled UDAs Total UDAs completed in month Apr-17 4000 5000 May-17 3500 4000 Jun-17 5000 6000 Jul-17 4700 5000 Aug-17 5000 6000 Sep-17 4800 5000 Oct-17 5200 4000 Nov-17 3800 1000 Dec-17 Jan-18 Feb-18 Mar-18 £1,255,000.00 Start date for prototype 01/04/2016 2017-18delivery requirements Contract Value Carried Forward - Previous Year £5,000.00 XXXXX Dental Prototype blend A £725,000.00 £530,000.00 Total UDAs delivered - Scheduled activity vs. activity completed in month 2016017Capitation remuneration report - Prototype XXXXXXXX- November 2017 14,800 Expected Minimum Activity 18,500 Activity and Capitation Performance Tolerance Contractor's Expected Capitated Population 15,000 2016-17 transitional allowance (provisional) 200 Capitated patient list - patients seen in 36months Activity - Prototype UDAs delivered Provider name or company name Prototype reference number 95% 96% 96% 97% 97% 98% 98% 99% 99% 100% 100% Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 Series2 0 1000 2000 3000 4000 5000 6000 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 Capitation remuneration report These figures need to be entered into the “Practice information” section of the modelling tool Capitation section Activity section These figures can either be used directly, or can be used to calculate estimated figures for input into the “Estimated year- end delivery percentage” section of the modelling tool
  • 5. Prototype practice year-end calculation modelling tool Cells requiring manual input Practice name Practice information (from capitation remuneration report) Actual Annual Prototype Value (AAPV) Capitation element (AAPV-C) Activity element (AAPV-A) Expected patient list (CECP) Transitional allowance Expected Capitated Population 0 less transitional allow ance Expected Minimum Activity (EMA) Contract value c/fwd - previous year (£) Estimated year-end delivery percentage (practice's own figures) Prototype UDAs (number); or Prototype UDAs (percentage) Estimated patient numbers Estimated UDAs 0 Step 1 - Year end delivery percentage for capitation and activity Capitation #DIV/0! Activity #DIV/0! Step 2 - Apply rules for adjustments for activity and capitation delivery (exchange mechanism) Capitation #DIV/0! Activity #DIV/0! Step 3 - Combine the year end achievement for capitation and activty Capitation #DIV/0! Activity #DIV/0! Total #DIV/0! % total #DIV/0! Step 4 - Apply carry forward from previous year Carry forward from previous year £0.00 #DIV/0! % total #DIV/0! Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML) Total #DIV/0! % total #DIV/0! #DIV/0! Step 5 - Calculate the final position and carry forward (if applicable) for next year Initial year-end value #DIV/0! Initial year-end percentage #DIV/0! Step 5a - Apply tolerances to carry forward figures Final year-end value #DIV/0! #DIV/0! Final year-end percentage #DIV/0! For every 100 UDAs below your expected minimum activity level (EMA) #DIV/0! extra patients are required to achieve the same financial value The figures from the top section of the capitation remuneration report are entered here The actual, or estimated figures, based on the capitation and activity sections of the capitation remuneration report are entered here
  • 6. Prior year under-performance Required patients at March 2018 (minus transitional allowance) Actual Annual Prototype Value - Capitation Element (AAPV-C) Actual Annual Prototype Value - Activity Element (AAPV-A) Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A) Start date for prototype 01/04/2016 2017-18delivery requirements Contract Value Carried Forward - Previous Year Prototype blend A 2016017Capitation remuneration report - Prototype XXXXXXXX- November2017 Expected Minimum Activity Activity and Capitation Performance Tolerance Contractor's Expected Capitated Population 2016-17 transitional allowance (provisional) Provider name or company name Prototype reference number Prototype practice year-end calculation modelling tool Cells requiring manual input Practice name Practice information (from capitation remuneration report) Actual Annual Prototype Value (AAPV) Capitation element (AAPV-C) Activity element (AAPV-A) Expected patient list (CECP) Transitional allowance Expected Capitated Population 0 Expected Minimum Activity (EMA) Contract value c/fwd - previous year (£) Estimated year-end delivery percentage (practice's own figures) Prototype UDAs (number); or Prototype UDAs (percentage) Estimated patient numbers Estimated UDAs 0 £725,000 £530,000 15,000 200 14,800 18,500 XXXXX Dental (2) The modelling tool will identify whether this represents prior year under or over-performance (1) Please ensure that you populate the modelling tool with the appropriate figures from the top section of the capitation remuneration report Iike this XXXXX Dental £1,255,000 £725,000 £530,000 15,000 £1,255,000 200 18,500 £5,000£5,000 (3) Input one figure in respect of estimated UDAs, either a percentage estimate or an actual number in the appropriate cell (4) Input the capitation figure from the latest capitation remuneration report , or your own forecast figure This is a sub-total Top section of the capitation remuneration report 1 2 4 5 3 2 3 1 4 6 5 6 7 8 7 8
  • 7. Required patients at March 2018 (minus transitional allowance) Actual Annual Prototype Value - Capitation Element (AAPV-C) Actual Annual Prototype Value - Activity Element (AAPV-A) Actual Annual Prototype Value (AAPV=AAPV-C + AAPV-A) Month 36 - month actual capitated patient numbers (new rules) New joiners needed per remaining month (new rules) New joiners needed plus imminent lapsers % of expected patient numbers currently delivering (new rules) % of expected patient numbers currently delivering including transitional allowance Apr-17 14500 42 97% 98% 12 May-17 14600 36 97% 99% 11 Jun-17 14650 35 98% 99% 10 Jul-17 14700 33 98% 99% 9 Aug-17 14750 31 98% 100% 8 Sep-17 14850 21 99% 100% 7 Oct-17 14900 17 99% 101% 6 Nov-17 14925 15 138 100% 101% 5 Dec-17 Jan-18 Feb-18 Mar-18 £1,255,000.00 Start date for prototype 01/04/2016 2017-18 delivery requirements Contract Value Carried Forward - Previous Year £5,000.00 XXXXX Dental Prototype blend A £725,000.00 £530,000.00 2016017 Capitation remuneration report - Prototype XXXXXXXX- November 2017 14,800 Expected Minimum Activity 18,500 Activity and Capitation Performance Tolerance Contractor's Expected Capitated Population 15,000 2016-17 transitional allowance (provisional) 200 Capitated patient list - patients seen in 36 months Provider name or company name Prototype reference number 95% 96% 96% 97% 97% 98% 98% 99% 99% 100% 100% Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 Capitation figures – Where do I get them from? Top half of the November 2017 capitation remuneration report (1) Identify the month that the report relates to (2) Identify the capitation figure for that month for the modelling tool, or use your own estimate
  • 8. Activity figures – Where do I get them from? Month Prototype UDAs carried out in month Prototype UDAs cumulative total Expected prototype UDAs % of expected Prototype UDAs achieved RAG Green100% or Apr-17 350 350 583 60% May-17 320 670 1167 57% Jun-17 300 970 1750 55% Jul-17 270 1240 2333 53% Aug-17 370 1610 2917 55% Sep-17 380 1990 3500 57% Oct-17 230 2220 4083 54% Nov-17 400 2620 4667 56% Dec-17 2620 5250 Jan-18 2620 5833 Feb-18 2620 6417 Mar-18 2620 7000 Month Total Scheduled UDAs Total UDAs completed in month Apr-17 300 600 May-17 530 560 Jun-17 430 530 Jul-17 650 540 Aug-17 587 480 Sep-17 483 600 Oct-17 670 670 Nov-17 730 400 Dec-17 Jan-18 Feb-18 Mar-18 Total UDAs delivered - Scheduled activity vs. activity completed in month Activity - Prototype UDAs delivered 0 1000 2000 3000 4000 5000 6000 7000 8000 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Series1 Series2 0 100 200 300 400 500 600 700 800 0 100 200 300 400 500 600 700 800 Bottom half of the November 2017 capitation remuneration report (1) From the top half of the report, identify the month that the report relates to. This is the November 2017 report (2) Identify the month that is two months earlier than the reporting month. This is because practices have two months to submit claims (3) Select the percentage achievement from the month two months earlier than the reporting month to enter into the modelling tool, or use your own estimate
  • 9. What do the modelling tool figures mean?
  • 10. Prototype practice year-end calculation modelling tool Cells requiring manual input Practice name XXXXX Dental Practice information (from capitation remuneration report) Actual Annual Prototype Value (AAPV) £1,255,000.00 Capitation element (AAPV-C) £725,000.00 Activity element (AAPV-A) £530,000.00 Expected patient list (CECP) 15,000 Transitional allowance 200 Expected Capitated Population 14,800 less transitional allow ance Expected Minimum Activity (EMA) 18,500 Contract value c/fwd - previous year (£) £5,000.00 Prior year under-performance Estimated year-end delivery percentage (practice's own figures) Prototype UDAs (number); or Prototype UDAs (percentage) 92.00% Estimated patient numbers 14,925 Estimated UDAs 17,020 Modelling tool – top half (1) You will have input these figures into the modelling tool as explained in slide 6 earlier in the presentation (2) Now input your estimated capitation and activity figures, either based on the capitation remuneration report or you own calculations
  • 11. Step 1 - Year end deliverypercentage for capitation and activity Capitation 100.83% Activity 92.00% Step 2 - Applyrules for adjustments for activityand capitation delivery(exchange mechanism) Capitation 100.83% Activity 92.00% Step 3 - Combine the year end achievement for capitation and activty Capitation £731,041.67 Activity £487,600.00 Total £1,218,641.67 % total 97.10% Step 4 - Applycarryforward fromprevious year Carry forward from previous year Prior year under-performance £5,000.00 £1,213,641.67 % total 96.70% Step 4a - Additional calculation if initial Y/E position is less than 90% (SFE 4.6 - CAAML) Total £1,213,641.67 % total 96.70% Step 5 - Calculate the final position and carryforward (if applicable) for next year Initial year-end value £41,358.33 Initial year-end percentage 3.30% Step 5a - Applytolerances to carryforward figures Final year-end value Under-performance £41,358.33 Final year-end percentage 3.30% For every 100 UDAs below your expected minimum activity level (EMA) 59.27 extra patients are required to achieve the same financial value Modelling tool – bottom half Step 1 – Raw capitation and activity performance Step 2 – Exchange mechanism rules are applied to raw capitation and activity performance, if criteria are met Step 3 – The step 2 percentages are then applied separately to the capitation and activity contract values and added together to give an overall total Step 4 – The step 3 total value is then adjusted to take into account any carry forward from the previous year. A revised percentage is calculated Step 4a – Only applies to cases where the step 4 overall percentage is less than 90%. This step limits the under- performance to 90%, otherwise the step 4 total appliesStep 5 – This calculates the final year-end carry forward figure where appropriate, or identifies the amount to be paid back where performance is less than 96% Step 5a – only applies where the practice over-performs by more than 2%. This step limits any over- performance to 2%, otherwise the step 5 total applies
  • 12. Exchange mechanism The exchange mechanism enables practices to offset under- performance on activity by over-performance on capitation, NOT vice-versa. Where practices utilise the exchange mechanism, the bottom of the modelling tool states how many additional patients you need to see for every 100 UDAs you are below your expected minimum activity For every 100 UDAs below your expected minimum activity level (EMA) 59.27 extra patients are required to achieve the same financial value A separate exchange mechanism briefing will be published separately
  • 13. Further support If you still require further assistance please contact dentalcontractreform@pcc.nhs.uk The modelling tool can be downloaded from www.pcc-cic.org.uk/article/making-it-work-practice